SCHEMBL31688345

SCHEMBL31688345

CC(C)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NMUR2 Q9GZQ4 5/20 0.64
▸ NMUR1 Q9HB89 5/20 0.64
▸ RAMP3 O60896 5/20 0.58
▸ CALCR P30988 5/20 0.58
▸ NPY2R P49146 7/20 0.57
▸ NPY4R P50391 7/20 0.57
▸ NPY5R Q15761 7/20 0.57
▸ NPY1R P25929 5/20 0.57
▸ APLNR P35414 1/20 0.56
▸ TFPI P10646 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680005 0.90 NMUR2 (0.64) NMUR2NMUR1RAMP3CALCRNPY2R
SCHEMBL31683362 0.89 RAMP3 (0.64) NMUR2NMUR1RAMP3CALCRNPY2R
SCHEMBL29416002 0.88 NMUR2 (0.65) NMUR2NMUR1APLNRTFPI
SCHEMBL30527874 0.88 NMUR2 (0.65) NMUR2NMUR1APLNRTFPI
SCHEMBL30429119 0.88 NPY2R (0.67) NMUR2NMUR1RAMP3CALCRNPY2R
SCHEMBL30607289 0.88 NPY2R (0.67) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL31572089 0.88 EPHA2 (0.61) NMUR2NMUR1APLNR
SCHEMBL31683346 0.87 EPHA2 (0.60) NMUR2NMUR1RAMP3CALCRNPY2R
SCHEMBL38665603 0.87 EPHA2 (0.60) NMUR2NMUR1RAMP3CALCR
SCHEMBL30431273 0.86 NMUR2 (0.65) NMUR2NMUR1NPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250297282-A1 VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE JUNO THERAPEUTICS GMBH (DE) 2025-09-25 — — US disclosed
Send feedback